Trusted Resources: Education
Scientific literature and patient education texts
Transthyretin Glu54Leu – An Unknown Mutation Within the Swedish Population Associated With Amyloid Cardiomyopathy and a Unique Fibril Type
source: Scandinavian Journal of Clinical and Laboratory Investigation
year: 2019
authors: Hellman U, Lång K, Ihse E, Jonasson J, Olsson M, Lundgren HE, Pilebro B, Westermark P, Wixner J, Anan I
summary/abstract:For the first time, we report of a Swedish family of five individuals with a TTR Glu54Leu (p. Glu74Leu) mutation in the transthyretin gene. This mutation has been previously described a few times in the literature, but no phenotypic or clinical description has been done before.
The most common mutation in the Swedish population is TTRVal30Met and is mostly found in the Northern part of Sweden. Interestingly, the TTRGlu54Leu mutation was found in the same endemic area. The main phenotype of the TTR Glu54Leu patients is severe cardiomyopathy, which resulted in heart transplantation for the index person.
As previously seen for ATTR amyloidosis patients with mainly cardiomyopathy, the amyloid fibrils consisted of a mixture of full-length and fragmented TTR species. However, western blot analyses detected a previously unrecognized band, indicating that these patients may have a third, so far unrecognized, fibril composition type that is distinct from the usual type A band pattern.
organization: Umeå University, Sweden; Piteå Hospital, Sweden; Uppsala University, SwedenDOI: 10.1080/00365513.2019.1624977
read more full text
Related Content
-
Diagnosis, Prognosis, and Therapy of Transthyretin AmyloidosisTransthyretin amyloidosis is a fatal dis...
-
US FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid CardiomyopathyPfizer Inc. announced today that the US ...
-
Hereditary ATTR Amyloidosis: Burden of Illness and Diagnostic ChallengesHereditary transthyretin-mediated (hATTR...
-
Landmark CRISPR Trial Shows Promise Against Deadly DiseasePreliminary results from a landmark clin...
-
Newer Therapies for Amyloid CardiomyopathyThe heart and the kidneys are the most c...
-
How to Talk With Your Family About Your hATTR Amyloidosis Diagnosis?Talking to your family members about you...
-
Amyloid CardiomyopathyCardiac amyloidosis is a heterogeneous g...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.